298 related articles for article (PubMed ID: 25280631)
1. Uptake and degradation of protease-sensitive and -resistant forms of abnormal human prion protein aggregates by human astrocytes.
Choi YP; Head MW; Ironside JW; Priola SA
Am J Pathol; 2014 Dec; 184(12):3299-307. PubMed ID: 25280631
[TBL] [Abstract][Full Text] [Related]
2. Analyses of protease resistance and aggregation state of abnormal prion protein across the spectrum of human prions.
Saverioni D; Notari S; Capellari S; Poggiolini I; Giese A; Kretzschmar HA; Parchi P
J Biol Chem; 2013 Sep; 288(39):27972-85. PubMed ID: 23897825
[TBL] [Abstract][Full Text] [Related]
3. Pathogenic mutations within the hydrophobic domain of the prion protein lead to the formation of protease-sensitive prion species with increased lethality.
Coleman BM; Harrison CF; Guo B; Masters CL; Barnham KJ; Lawson VA; Hill AF
J Virol; 2014 Mar; 88(5):2690-703. PubMed ID: 24352465
[TBL] [Abstract][Full Text] [Related]
4. The Size and Stability of Infectious Prion Aggregates Fluctuate Dynamically during Cellular Uptake and Disaggregation.
Shoup D; Priola SA
Biochemistry; 2021 Feb; 60(5):398-411. PubMed ID: 33497187
[TBL] [Abstract][Full Text] [Related]
5. Development of oligomeric prion-protein aggregates in a mouse model of prion disease.
Sasaki K; Minaki H; Iwaki T
J Pathol; 2009 Sep; 219(1):123-30. PubMed ID: 19479969
[TBL] [Abstract][Full Text] [Related]
6. Analysis of Conformational Stability of Abnormal Prion Protein Aggregates across the Spectrum of Creutzfeldt-Jakob Disease Prions.
Cescatti M; Saverioni D; Capellari S; Tagliavini F; Kitamoto T; Ironside J; Giese A; Parchi P
J Virol; 2016 Jul; 90(14):6244-6254. PubMed ID: 27122583
[TBL] [Abstract][Full Text] [Related]
7. Transmission characteristics of heterozygous cases of Creutzfeldt-Jakob disease with variable abnormal prion protein allotypes.
Ward A; Hollister JR; McNally K; Ritchie DL; Zanusso G; Priola SA
Acta Neuropathol Commun; 2020 Jun; 8(1):83. PubMed ID: 32517816
[TBL] [Abstract][Full Text] [Related]
8. An antibody to the aggregated synthetic prion protein peptide (PrP106-126) selectively recognizes disease-associated prion protein (PrP) from human brain specimens.
Jones M; Wight D; McLoughlin V; Norrby K; Ironside JW; Connolly JG; Farquhar CF; MacGregor IR; Head MW
Brain Pathol; 2009 Apr; 19(2):293-302. PubMed ID: 18507665
[TBL] [Abstract][Full Text] [Related]
9. Protease-resistant human prion protein and ferritin are cotransported across Caco-2 epithelial cells: implications for species barrier in prion uptake from the intestine.
Mishra RS; Basu S; Gu Y; Luo X; Zou WQ; Mishra R; Li R; Chen SG; Gambetti P; Fujioka H; Singh N
J Neurosci; 2004 Dec; 24(50):11280-90. PubMed ID: 15601934
[TBL] [Abstract][Full Text] [Related]
10. Correlation of polydispersed prion protein and characteristic pathology in the thalamus in variant Creutzfeldt-Jakob disease: implication of small oligomeric species.
Choi YP; Gröner A; Ironside JW; Head MW
Brain Pathol; 2011 May; 21(3):298-307. PubMed ID: 21029243
[TBL] [Abstract][Full Text] [Related]
11. Early appearance but lagged accumulation of detergent-insoluble prion protein in the brains of mice inoculated with a mouse-adapted Creutzfeldt-Jakob disease agent.
Nakaoke R; Sakaguchi S; Atarashi R; Nishida N; Arima K; Shigematsu K; Katamine S
Cell Mol Neurobiol; 2000 Dec; 20(6):717-30. PubMed ID: 11100979
[TBL] [Abstract][Full Text] [Related]
12. A new method for the characterization of strain-specific conformational stability of protease-sensitive and protease-resistant PrPSc.
Pirisinu L; Di Bari M; Marcon S; Vaccari G; D'Agostino C; Fazzi P; Esposito E; Galeno R; Langeveld J; Agrimi U; Nonno R
PLoS One; 2010 Sep; 5(9):e12723. PubMed ID: 20856860
[TBL] [Abstract][Full Text] [Related]
13. Small protease sensitive oligomers of PrPSc in distinct human prions determine conversion rate of PrP(C).
Kim C; Haldiman T; Surewicz K; Cohen Y; Chen W; Blevins J; Sy MS; Cohen M; Kong Q; Telling GC; Surewicz WK; Safar JG
PLoS Pathog; 2012; 8(8):e1002835. PubMed ID: 22876179
[TBL] [Abstract][Full Text] [Related]
14. A novel form of human disease with a protease-sensitive prion protein and heterozygosity methionine/valine at codon 129: Case report.
Rodríguez-Martínez AB; Garrido JM; Zarranz JJ; Arteagoitia JM; de Pancorbo MM; Atarés B; Bilbao MJ; Ferrer I; Juste RA
BMC Neurol; 2010 Oct; 10():99. PubMed ID: 20973975
[TBL] [Abstract][Full Text] [Related]
15. Tetracycline affects abnormal properties of synthetic PrP peptides and PrP(Sc) in vitro.
Tagliavini F; Forloni G; Colombo L; Rossi G; Girola L; Canciani B; Angeretti N; Giampaolo L; Peressini E; Awan T; De Gioia L; Ragg E; Bugiani O; Salmona M
J Mol Biol; 2000 Jul; 300(5):1309-22. PubMed ID: 10903871
[TBL] [Abstract][Full Text] [Related]
16. Co-existence of scrapie prion protein types 1 and 2 in sporadic Creutzfeldt-Jakob disease: its effect on the phenotype and prion-type characteristics.
Cali I; Castellani R; Alshekhlee A; Cohen Y; Blevins J; Yuan J; Langeveld JP; Parchi P; Safar JG; Zou WQ; Gambetti P
Brain; 2009 Oct; 132(Pt 10):2643-58. PubMed ID: 19734292
[TBL] [Abstract][Full Text] [Related]
17. An astrocyte cell line that differentially propagates murine prions.
Tahir W; Abdulrahman B; Abdelaziz DH; Thapa S; Walia R; Schätzl HM
J Biol Chem; 2020 Aug; 295(33):11572-11583. PubMed ID: 32561641
[TBL] [Abstract][Full Text] [Related]
18. The Distribution of Prion Protein Allotypes Differs Between Sporadic and Iatrogenic Creutzfeldt-Jakob Disease Patients.
Moore RA; Head MW; Ironside JW; Ritchie DL; Zanusso G; Choi YP; Priola SA
PLoS Pathog; 2016 Feb; 12(2):e1005416. PubMed ID: 26840342
[TBL] [Abstract][Full Text] [Related]
19. Molecular Subtyping of PrP
Klug GM; Lewis V; Collins SJ
Methods Mol Biol; 2017; 1658():347-354. PubMed ID: 28861800
[TBL] [Abstract][Full Text] [Related]
20. Acidic pH and detergents enhance in vitro conversion of human brain PrPC to a PrPSc-like form.
Zou WQ; Cashman NR
J Biol Chem; 2002 Nov; 277(46):43942-7. PubMed ID: 12161431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
